Carregant...
Targeting HER2 beyond breast cancer
The structural basis of blocking human epidermal growth factor receptor-2 (HER2) dimerization remains of great interest to generate effective anti-cancer therapies. Despite clinically feasible outcome in mammary tumors, a fine consensus between efficacy and safety remains a critical challenge beyond...
Guardat en:
| Publicat a: | Mol Cell Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512921/ https://ncbi.nlm.nih.gov/pubmed/31131305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2019.1571984 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|